,14 Among genetic and epigenetic factors, inactivation of the p16ink4a gene (cyclin-dependent kinase inhibitor 2a, CDKN2A) by point mutations, deletions, and methylation, has been reported in a large number of other cancers, an event that might also contribute to cervical cancer development.15 This evidence concerns the gene CDKN2A and cancer.